Novo Nordisk, Denmark’s fat jab pharmaceutical giant, reached an unwelcome milestone last week. After a dizzying 76pc plunge ...

As Denmark begins talkswith the United States over a potential Greenland deal, the country’s largest industry may not give it much leverage in negotiations, experts told Euronews Health. Denmark’s top ...

Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations ...

Almost £150bn has been wiped off Ozempic drugmaker Novo Nordisk after a trial of its new weight-loss drug fell short of ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

Current health news includes Roche aiming for a market lead in weight loss, Aspen's profit growth forecasts, and the Guinea-USA health deal. Also, CMS plans sanctions on Elevance, autism researchers ...

Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a potential path forward for the Danish drugmaker as it ...

COPENHAGEN (Reuters) -Four patients in Denmark, who experienced vision loss after using Novo Nordisk's popular weight-loss and diabetes drugs ‌Wegovy and Ozempic, have been granted compensation, the ...

Ozempic started the weight-loss drug frenzy, and it continues to be a famous name in the fight against obesity, even though it's not approved for that purpose. The blockbuster medication is meant to ...